Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
Agency: National Institutes of Health
- 93.855 -- Allergy and Infectious Diseases Research
Open opportunityLast Updated: Oct 13, 2026
Important dates
- Closing: February 11, 2027
Award details
- Expected project funding: $4,000,000
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:RFA-AI-28-024
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: October 13, 2026
- Archive date: April 13, 2027
- Version: 1
Summary
Jump to documentsThe purpose of this notice of funding opportunity (NOFO) is to support research and/or preclinical development of highly efficacious vaccines against malaria - one of the deadliest mosquito-borne diseases - by capitalizing on recent technological innovations, particularly in structure-based immunogen design, improved formulations, and combination vaccines. The goal is to achieve long-lasting, highly effective protection that can save lives, strengthen public health security in the United States, and serve as a model for, or are potentially effective against, other mosquito-borne diseases.
Eligibility
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Government
- Federally recognized Native American tribal governments
- County governments
- Special district governments
- Public and Indian housing authorities
- City or township governments
- State governments
Education
- Independent school districts
- Private institutions of higher education
- Public and state institutions of higher education
Business
- Small businesses
- For-profit organizations other than small businesses
Miscellaneous
- Other
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-AI-28-024-Full-Announcement.html | RFA-AI-28-024-Full-Announcement.html | Oct 13, 2026 11:08 AM UTC |
Agency contact information
Email: MalariaandOtherMosquitoBorneDiseases@mail.nih.gov
MalariaandOtherMosquitoBorneDiseases@mail.nih.gov
Link to additional information
No additional information is available
